- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04333199
Timely Nudge About Lab Results to Increase myGeisinger Uptake
Nudging myGeisinger Enrollment Using Timely Email Messaging Reminding Patients of Lab Results Available
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Online patient portals are convenient tools that improve patient access to healthcare services while often reducing burden to both patients and providers. However, many patients have not enrolled in such portals, including Geisinger's patient portal, known as myGeisinger.
The purpose of the current study is to test whether sending myGeisinger enrollment information in a timely manner - when the benefits of enrolling are most readily available - increases enrollment. Specifically, messages will be timely in terms of lab test results having just been made available online, with the added benefit that patients can view their results prior to receiving them via mail. Unenrolled patients who recently had a laboratory procedure ordered and whose results are now ready for sharing will be informed via email that their lab results are available. At the same time, these patients will be reminded that these results can be viewed online through myGeisinger.
The primary outcome measure of interest, myGeisinger enrollment rates, will be compared between the emailed population and a control group that similarly has lab results available but will not be contacted. In addition, two different versions of the email communication will be tested. One will highlight that the patient will have to go through a sign-up process before viewing test results (in the service of transparency). The other will provide a presumed direct link to view those results, via a button that potentially serves as a pre-commitment step to undergo the registration process ("foot in the door" effect). Secondary analyses will assess differences in enrollment rates as well as unsubscribe rates between the email versions. Exploratory analyses will further examine differences in the rates at which patients opened and clicked on enrollment links within the two emails. Statistical analyses will employ generalized linear models with a binary distribution and log-link function.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Pennsylvania
-
Danville, Pennsylvania, Estados Unidos, 17822
- Geisinger
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Geisinger patient for whom a lab was ordered within 30 days prior to email date
- Patient's lab test result released day before email date
Exclusion Criteria:
- Patient already enrolled in myGeisinger
- Patient has already declined myGeisinger
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Pesquisa de serviços de saúde
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Control
Patients do not receive an email
|
|
|
Experimental: Timely nudge - view results
Patients are emailed about myGeisinger when they have a lab result ready to view.
The email includes a "View My Lab Results" button, which encourages them to click as a pre-commitment step that then brings them to the myGeisinger sign-up page.
|
Email
Email
|
|
Experimental: Timely nudge - get started
Patients are emailed about myGeisinger when they have a lab result ready to view.
The email includes a "Get Started With myGeisinger" button that is transparent about the next step in the process, before the patient can view test results.
|
Email
Email
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Enrollment - Timely Email (Combined Email Arms) vs. no Intervention
Prazo: 1 week post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 week post-intervention
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Enrollment - Email Including a "Get Started" Button vs. a "View Results" Button
Prazo: 1 week post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 week post-intervention
|
|
Email Opened - Email Including a "Get Started" Button vs. a "View Results" Button
Prazo: 1 week post-intervention
|
Email was opened (yes / no)
|
1 week post-intervention
|
|
Link Clicked - Email Including a "Get Started" Button vs. a "View Results" Button
Prazo: 1 week post-intervention
|
Link / button to start the enrollment process was clicked (yes / no)
|
1 week post-intervention
|
|
Unsubscribed - Email Including a "Get Started" Button vs. a "View Results" Button
Prazo: 1 month post-intervention
|
Patient unsubscribed from these email communications (yes / no)
|
1 month post-intervention
|
|
Enrollment - Timely Email (Combined Email Arms) vs. no Intervention
Prazo: 1 month post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 month post-intervention
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- 2020-0316
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Prazo de Compartilhamento de IPD
Critérios de acesso de compartilhamento IPD
Tipo de informação de suporte de compartilhamento de IPD
- ANALYTIC_CODE
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .